OUTLOOK THERAPEUTICS, INC. Accounts Payable
OUTLOOK THERAPEUTICS, INC. (OTLK) had Accounts Payable of $6.81 million as of 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-18
- 2026-06-30: Accounts Payable, Current $6.81M.
- 2026-03-31: Accounts Payable, Current $13.64M.
- 2025-12-31: Accounts Payable, Current $7.32M.
- 2025-09-30: Accounts Payable, Current $10.19M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $6.81M 10-Q · filed 2026-08-18 |
| 2026-03-31 | $13.64M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $7.32M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $10.19M 10-Q · filed 2026-08-18 |
| 2025-06-30 | $10.26M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $7.77M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $12.19M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $7.97M 10-K · filed 2025-12-19 |
| 2024-06-30 | $5.55M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $4.36M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $3.48M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $6.57M 10-K · filed 2024-12-27 |
| 2023-06-30 | $5.06M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $3.62M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $4.17M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $3.49M 10-K · filed 2023-12-22 |
| 2022-06-30 | $2.48M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $4.16M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $2.55M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $2.20M 10-K · filed 2022-12-29 |
| 2021-06-30 | $2.67M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $6.33M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $3.33M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $2.39M 10-K · filed 2021-12-23 |
| 2020-06-30 | $5.01M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $3.31M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $2.57M 10-Q · filed 2020-02-14 |
| 2019-09-30 | $2.28M 10-K · filed 2020-12-23 |
| 2019-06-30 | $2.99M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $5.11M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $4.70M 10-Q · filed 2019-02-14 |
| 2018-09-30 | $3.61M 10-K · filed 2019-12-19 |
| 2018-06-30 | $3.35M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $3.61M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $3.63M 10-Q · filed 2018-02-14 |
| 2017-09-30 | $10.95M 10-K · filed 2018-12-18 |
| 2017-06-30 | $11.79M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $12.15M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $11.05M 10-Q · filed 2017-02-14 |
| 2016-09-30 | $5.07M 10-K · filed 2017-12-29 |
| 2016-06-30 | $4.53M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $14.42M 10-Q · filed 2016-06-27 |
| 2015-09-30 | $11.56M 10-K · filed 2016-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |